For the fifth time in eight years, Professor Thomas Baumert at the Institute for Translational Medicine and Liver Diseases (Unistra/Inserm) has been awarded a prestigious ERC Proof of Concept Grant by the European Union. This new ERC (PACMAN) will enable the researcher and his team to develop an innovative therapeutic approach to treat pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer.
See the article on Savoir(s) | Le quotidien de l'Université de Strasbourg
